Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
633.04B
Market cap633.04B
Price-Earnings ratio
30.41
Price-Earnings ratio30.41
Dividend yield
1.99%
Dividend yield1.99%
Average volume
10.55M
Average volume10.55M
High today
$263.09
High today$263.09
Low today
$253.00
Low today$253.00
Open price
$256.40
Open price$256.40
Volume
8.00M
Volume8.00M
52 Week high
$263.10
52 Week high$263.10
52 Week low
$154.21
52 Week low$154.21

Stock Snapshot

With a market cap of 633.04B, Johnson & Johnson(JNJ) trades at $262.99. The stock has a price-to-earnings ratio of 30.41 and currently yields dividends of 1.99%.

As of 2026-07-05, Johnson & Johnson(JNJ) stock has fluctuated between $253.00 and $263.09. The current price stands at $262.99, placing the stock +3.9% above today's low and -0.0% off the high.

The Johnson & Johnson(JNJ)'s current trading volume is 8M, compared to an average daily volume of 10.55M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $263.10 and a 52-week low of $154.21.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $263.10 and a 52-week low of $154.21.

JNJ News

24/7 Wall St. 1h
How To Turn A Portfolio Into $500 A Month Without Chasing Dangerous Yields

How To Turn A Portfolio Into $500 A Month Without Chasing Dangerous Yields By Drew Wood Published Jul 5, 9:52AM EDT Quick Read Generating $500 a month from di...

How To Turn A Portfolio Into $500 A Month Without Chasing Dangerous Yields
Simply Wall St 8h
Johnson & Johnson Stock Looks Undervalued On Cash Flow While Earnings Look Fair

Johnson & Johnson stock has delivered a strong 80.3% return over the last three years, yet the valuation checks send a mixed message, with the Discounted Cash F...

Johnson & Johnson Stock Looks Undervalued On Cash Flow While Earnings Look Fair
New York Times 17h
Everton agree £24m Tyrique George deal with Chelsea - The New York Times

...

Everton agree £24m Tyrique George deal with Chelsea - The New York Times

Analyst ratings

69%

of 26 ratings
Buy
69.2%
Hold
26.9%
Sell
3.8%

More JNJ News

24/7 Wall St. 20h
The Portfolio That Lets You Go Part-Time Five Years Early

The Portfolio That Lets You Go Part-Time Five Years Early By Drew Wood Published Jul 4, 3:11PM EDT Quick Read Replacing $40,000 in lost income requires betwee...

The Portfolio That Lets You Go Part-Time Five Years Early
24/7 Wall St. 22h
What A $750,000 Dividend Portfolio Actually Pays After Taxes, Medicare Premiums, And Reality

What A $750,000 Dividend Portfolio Actually Pays After Taxes, Medicare Premiums, And Reality By Drew Wood Published Jul 4, 1:09PM EDT Quick Read A $750,000 po...

What A $750,000 Dividend Portfolio Actually Pays After Taxes, Medicare Premiums, And Reality
Nasdaq 2d
Johnson & Johnson Is Walking Away From a $100 Billion Obesity Market. Could That Actually Make It the Better Long-Term Buy Than Eli Lilly?

Key Points Johnson & Johnson's CEO recently explained that his company isn't going to get caught up in the GLP-1 weight loss drug race. Instead, the company w...

Johnson & Johnson Is Walking Away From a $100 Billion Obesity Market. Could That Actually Make It the Better Long-Term Buy Than Eli Lilly?
24/7 Wall St. 2d
The Portfolio That Pays For Season Tickets Forever

The Portfolio That Pays For Season Tickets Forever By Drew Wood Published Jul 3, 7:01AM EDT Quick Read Dividing your annual ticket cost by a portfolio yield s...

The Portfolio That Pays For Season Tickets Forever
Nasdaq 2d
Members of Congress Are Loading Up on Johnson & Johnson and UnitedHealth. Here's Why Retail Investors Should Pay Attention.

Key Points Rep. Lisa McClain (R-Mich.) has been a big buyer of Johnson & Johnson stock. Oklahoma Republican Sen. Markwayne Mullin has bought large chunks of U...

Members of Congress Are Loading Up on Johnson & Johnson and UnitedHealth. Here's Why Retail Investors Should Pay Attention.
Simply Wall St 3d
Is Johnson & Johnson Using IMAAVY’s gMG and Pregnancy Data to Deepen Its Immunology Moat?

In late June 2026, Johnson & Johnson presented new data on its FcRn blocker IMAAVY (nipocalimab-aahu) at the European Academy of Neurology Congress, highlightin...

Is Johnson & Johnson Using IMAAVY’s gMG and Pregnancy Data to Deepen Its Immunology Moat?
24/7 Wall St. 3d
$500 a Month in These Stocks Will Generate $6,700 in Passive Annual Income

$500 a Month in These Stocks Will Generate $6,700 in Passive Annual Income By Vandita Jadeja Published Jul 2, 11:02AM EDT Quick Read PFE yields 7.20% and JNJ...

$500 a Month in These Stocks Will Generate $6,700 in Passive Annual Income

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.